When.com Web Search

  1. Ads

    related to: epo boost review for patients

Search results

  1. Results From The WOW.Com Content Network
  2. Erythropoiesis-stimulating agent - Wikipedia

    en.wikipedia.org/wiki/Erythropoiesis-stimulating...

    The 2020 Cochrane Anaesthesia Review Group review of erythropoietin (EPO) plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery [11] demonstrated that patients were much less likely to require red cell transfusion and in those transfused, the volumes were unchanged (mean ...

  3. Blood doping - Wikipedia

    en.wikipedia.org/wiki/Blood_doping

    Blood doping is a form of doping in which the number of red blood cells in the bloodstream is boosted in order to enhance athletic performance. Because such blood cells carry oxygen from the lungs to the muscles, a higher concentration in the blood can improve an athlete's aerobic capacity (VO 2 max) and endurance. [1]

  4. Epoetin alfa - Wikipedia

    en.wikipedia.org/wiki/Epoetin_alfa

    Epoetin alfa, sold under the brand name Epogen among others, is a human erythropoietin produced in cell culture using recombinant DNA technology. [8] [9] Epoetin alfa is an erythropoiesis-stimulating agent. [8]

  5. Do Nitric Oxide Supplements Really Help With ED? - AOL

    www.aol.com/nitric-oxide-supplements-really-help...

    A review published in the journal Sports Medicine found that nitric oxide supplements do appear to offer exercise-related benefits, including increased exercise performance. It’s worth noting ...

  6. Erythropoietin - Wikipedia

    en.wikipedia.org/wiki/Erythropoietin

    n/a n/a Ensembl n/a n/a UniProt n a n/a RefSeq (mRNA) n/a n/a RefSeq (protein) n/a n/a Location (UCSC) n/a n/a PubMed search n/a n/a Wikidata View/Edit Human Erythropoietin (/ ɪ ˌ r ɪ θ r oʊ ˈ p ɔɪ. ɪ t ɪ n, - r ə -, - p ɔɪ ˈ ɛ t ɪ n, - ˈ iː t ɪ n / ; EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys ...

  7. Continuous erythropoietin receptor activator - Wikipedia

    en.wikipedia.org/wiki/Continuous_erythropoietin...

    Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA) in January 2008 to market a continuous erythropoiesis receptor activator (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia in patients with chronic kidney disease, including in those undergoing dialysis.